apollo
0
Prescription drug
 Trailing icon
Consult Doctor

Composition

DACOMITINIB-30MG

Manufacturer/Marketer

Pfizer Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Dacoplice 30 mg Tablet

Dacoplice 30 mg Tablet is an anti-cancer medicine used in the treatment of non-small cell lung cancer (NSCLC). It is a common form of lung cancer in which abnormal cells grow in the lung tissues. Dacoplice 30 mg Tablet is used as a first-line therapy in the treatment of metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations.

Dacoplice 30 mg Tablet consists of Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of an enzyme (tyrosine kinase) that causes the multiplication of cancerous cells. This prevents the abnormal growth of cancer cells and thus reduces the further spread to other parts of the body.

Dacoplice 30 mg Tablet may cause certain side effects such as diarrhea, rash, nausea, vomiting, dry skin, mouth sores, nail inflammation, ache, cough, abdominal pain, hair loss, decreased appetite, decreased weight loss, and itching. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Dacoplice 30 mg Tablet should be taken as advised by your doctor. Do not take more than the recommended dose. Your doctor will decide the dose of Dacoplice 30 mg Tablet based on the severity of your condition.

Avoid taking Dacoplice 30 mg Tablet if you are allergic to it or any other components of it. Before taking Dacoplice 30 mg Tablet , inform your doctor if you have/had liver or kidney disease and lung disease other than lung cancer. This medicine is known to cause embryo-fetal toxicity. It is not recommended for use in pregnancy and breastfeeding. Elderly people are more sensitive to medicine, so the dose may have to be adjusted according to their condition.

Uses of Dacoplice 30 mg Tablet

Treatment of Non-small cell lung cancer (NSCLC)

Medicinal Benefits

Dacoplice 30 mg Tablet contains Dacominitib, which belongs to the class of medicines known as kinase inhibitors. It works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other parts of the body. In this way, Dacoplice 30 mg Tablet stops the body's production, spread and growth of cancerous cells.

Side Effects of Dacoplice 30 mg Tablet

  • Dry skin
  • Nausea
  • Rash
  • Pruritus (itching)
  • Vomiting
  • Diarrhoea
  • Loss of appetite
  • Itching or skin rash
  • Mouth sores
  • Decreased weight loss
  • Nail inflammation
  • Dry, red and itchy eyes
  • Abdominal pain

Directions for Use

Take Dacoplice 30 mg Tablet as prescribed by the doctor. Swallow it as a whole with a glass of water. Do not crush, break, or chew it.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

To treat your condition effectually, continue taking Dacoplice 30 mg Tablet for the period that your doctor has prescribed. Avoid taking Dacoplice 30 mg Tablet if you are allergic to it or any other components present in it. Caution should be exercised if you have/had liver or kidney disease, eye problems, lung disease other than lung cancer, severe cough, and breathing difficulty. This medicine is known to cause embryo-fetal toxicity. Hence, inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment. Effective birth control pills should be used for at least 17 days after the last dose of the medicine. Dacoplice 30 mg Tablet may cause severe diarrhea, severe skin conditions, and Interstitial lung disease in some patients. Hence, inform your doctor about your complete medication and medical history before taking Dacoplice 30 mg Tablet . Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. Avoid driving and operating machines, as this medicine may cause visual disturbances. This medicine is not recommended for use in children as the safety and efficacy are not established.

Therapeutic Class

ANTINEOPLASTIC

Drug Interactions

Drug-Drug Interaction: Dacoplice 30 mg Tablet may have interaction with Proton Pump Inhibitors (esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole), Cytochrome-P 450 (CYP2D6) substrate drugs (Codeine, haloperidol, aripiprazole, Nortriptyline)

Drug-Food Interaction: No interaction found.

Dug-Disease Interaction: Tell your doctor if you have liver or kidney disease, vision problems, lung disease, and breathing problems.

Drug-Drug Interactions Checker List

  • ESOMEPRAZOLE
  • RABEPRAZOLE
  • PANTOPRAZOLE
  • LANSOPRAZOLE
  • CODEINE
  • HALOPERIDOL
  • ARIPIPRAZOLE
  • NORTRIPTYLINE

Diet & Lifestyle Advise

  • After your treatment begins, several dietary adjustments can help you control side effects.
  • Anyone suffering from a chronic illness, including cancer, should consume foods high in protein, healthy fats, whole grains, and vitamins and minerals.
  • Plant-based proteins are among the greatest meals during chemotherapy or other cancer treatments. They have the highest concentrations of vitamins and minerals, such as nuts, seeds, beans and legumes.
  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
  • Performing yoga may also help in improving both physical and mental health.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.
  • Avoid fast food, fried food, processed meats, refined carbs and added sugars.

Habit Forming

No

What if I have taken an overdose of Dacoplice 30 mg Tablet

Do not take more than the prescribed dose. Using more medication will not improve your symptoms; instead, they may cause serious side effects or poisoning. If you suspect that you may have overdosed of Dacoplice 30 mg Tablet or observe any side effects, please go to the emergency department of the closest hospital or nursing home. No specific side effects have been reported under these circumstances.

Special Advise

  • Avoid being under the sun for a long time, as prolonged duration of sun exposure may cause serious hypersensitivity reactions.
  • Your doctor may suggest blood tests to check for any changes in the patient during the treatment period.

Disease/Condition Glossary

Non-Small Cell Lung Cancer (NSCLC): Lung cancer is defined as an Uncontrollable growth of abnormal cells in one or both lungs. These abnormal cells do not carry out normal lung cell functions and do not develop into healthy lung tissue. There are different forms of lung cancer. The most common form of lung cancer is non-small cell lung cancer (NSCLC). It happens when cells that form the lining of the lung start growing uncontrollably. Cancerous cells of the lung spread off and travel through the bloodstream to distant regions of the body and grow. It is mostly seen in persons who smoke. Symptoms may include chest pain, weight loss, hoarseness, and difficulty breathing.

bannner image

Alcohol

Consult your doctor

It is unknown whether alcohol may interact with Dacoplice 30 mg Tablet . However, as a precautionary measure, it is advisable not to take or limit alcohol. Consult your doctor for more information.

bannner image

Pregnancy

Unsafe

Dacoplice 30 mg Tablet is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Dacoplice 30 mg Tablet . You should not become pregnant while you are taking Dacoplice 30 mg Tablet and for at least 17 days after your last dose.

bannner image

Breast Feeding

Unsafe

It is not known whether Dacoplice 30 mg Tablet is present in human milk. However, you should not breastfeed while taking this medicine and, for 17 days after your last dose.

bannner image

Driving

Unsafe

Dacoplice 30 mg Tablet may cause blurred vision as a side effect. Hence, try to avoid driving, operating machinery, or engaging in any activity that needs clear vision until you are able to see clearly while you are on treatment with Dacoplice 30 mg Tablet .

bannner image

Liver

Caution

If you have mild to moderate liver problems, inform your doctor before taking Dacoplice 30 mg Tablet . The dose of this medicine has to be adjusted in case you have severe liver disease.

bannner image

Kidney

Caution

Inform your doctor before receiving Dacoplice 30 mg Tablet if you have a history of kidney diseases. No dose adjustments are required in mild to moderate renal impairment.

bannner image

Children

Unsafe

Dacoplice 30 mg Tablet is not recommended for children as the safety and effectiveness were not established.

Country of origin

INDIA

Manufacturer/Marketer address

The Capital, 1802, 18Th Floor , Plot No. C-70, €˜G’ Block , Bandra Kurla Complex, Bandra East , Mumbai €“ 400051
Other Info - DAC0062

FAQs

Dacoplice 30 mg Tablet is used to treat Non-small cell lung cancer (NSCLC).
Dacoplice 30 mg Tablet contains Dacominitib, which works by stopping the action of a tyrosine kinase enzyme that causes the multiplication of cancerous cells.
The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer, followed by coughing.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Add to Cart